DV
Dividend Vision

CORT — Corcept Therapeutics Incorporated

Corcept Therapeutics Incorporated (CORT)

Total return is 836.0% over the past 22.3 years, 94.5 points behind SPY at 930.5%. Its deepest 1-year drawdown was 64.4%.

This is a single-stock holding in Corcept Therapeutics Incorporated, a pharmaceutical company, rather than a diversified ETF fund. As an individual equity security, it does not have the typical characteristics of an ETF such as a stated fund objective, expense ratio, or regular dividend distributions. This holding appeals primarily to investors seeking direct exposure to a specific biotech/pharmaceutical company rather than those seeking diversified dividend income or broad market participation.

CORT key facts

Asset type
Stock
Asset class
Equity
Inception date
04/14/2004
Distribution frequency
None
Last close
$114.47
Market cap
$12,374,024,192
Average volume
728900.0
Beta
0.455
Payout ratio
0.0
P/E ratio
254.3778
Forward P/E
58.1395
EPS
$0.45